Interleukin-1-beta inhibitor - Aventis
Alternative Names: IL-1-beta antagonist - Aventis; IL-1-beta inhibitor - Aventis; Interleukin-1-beta antagonist - AventisLatest Information Update: 04 Jul 2002
At a glance
- Originator Aventis
- Class
- Mechanism of Action Interleukin 1 beta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 11 Jul 2000 Preclinical development for Rheumatoid arthritis (Unknown route)